Medicare Enrolled

Dr. Ana Seijas, M.D.

Internal Medicine · Palatka, FL
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
1302 RIVER ST, Palatka, FL 32177
3863288371
Registered in NPPES since 2006
NPI: 1679677249 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Seijas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seijas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Seijas

Dr. Ana Seijas is an internal medicine specialist in Palatka, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Seijas performed 15 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Seijas received a total of $2,346 from 27 pharmaceutical and/or device companies across 134 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Seijas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 15 Medicare services $2,346 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
15
Medicare services
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
15 $10 $70
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,346
Total received (2018-2024)
Avg $335/year across 7 years
Top 24% in FL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
134
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$862
2023
$489
2022
$399
2021
$307
2020
$41
2019
$169
2018
$80

Payments by company (2024)

Novo Nordisk Inc
$183
AstraZeneca Pharmaceuticals LP
$95
Amgen Inc.
$92
Lilly USA, LLC
$78
Exact Sciences Corporation
$62
PFIZER INC.
$56
Vanda Pharmaceuticals Inc.
$56
Insulet Corporation
$55
ABBVIE INC.
$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Gilead Sciences, Inc.
$35
GlaxoSmithKline, LLC.
$32
Astellas Pharma US Inc
$20
Medtronic, Inc.
$15
Top 3 companies account for 42.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$294
AbbVie Inc.
$272
Lilly USA, LLC
$164
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
Gilead Sciences, Inc.
$136
PFIZER INC.
$134
Amgen Inc.
$128
GlaxoSmithKline, LLC.
$128
AstraZeneca Pharmaceuticals LP
$120
Exact Sciences Corporation
$110
Novartis Pharmaceuticals Corporation
$75
ABBVIE INC.
$71
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$67
Astellas Pharma US Inc
$64
Bayer HealthCare Pharmaceuticals Inc.
$60
Mannkind Corporation
$59
Vanda Pharmaceuticals Inc.
$56
Insulet Corporation
$55
Teva Pharmaceuticals USA, Inc.
$53
Boston Scientific Corporation
$30
Otsuka America Pharmaceutical, Inc.
$28
Cranial Technologies, Inc
$20
Abbott Laboratories
$19
Medtronic, Inc.
$15
Adlon Therapeutics L.P.
$15
AbbVie, Inc.
$15
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MYCITE · ADHANSIA XR · AFREZZA · AIRSUPRA · AUSTEDO · Austedo XR · BEXSERO · COMIRNATY · Cologuard Collection Kit · Doc Band · ELIQUIS · EMGALITY · ENTRESTO · Epclusa · FARXIGA · FREESTYLE LIBRE 2 · HETLIOZ · JARDIANCE · Kerendia · MOUNJARO · MYRBETRIQ · Mavyret · Myrbetriq · Omnipod · Otezla · Ozempic · PAXLOVID · PEDIARIX · RYBELSUS · Rybelsus · SHINGRIX · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TRULICITY · Tresiba · VENASEAL · VRAYLAR · Veozah · WaveWriter Alpha Prime 16 · Wegovy · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an internal medicine specialist in Palatka?
Compare internal medicine physicians in the Palatka area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians in nearby ZIP areas
59
County median income
$47,256
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA PUTNAM HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Seijas is a remote monitoring specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Seijas experienced with hemoglobin a1c test (diabetes monitoring)?
Based on Medicare claims data, Dr. Seijas performed 15 hemoglobin a1c test (diabetes monitoring) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Seijas receive payments from pharmaceutical companies?
Yes. Dr. Seijas received a total of $2,346 from 27 companies across 134 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Seijas's costs compare to other internal medicine physicians in Palatka?
Dr. Seijas's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Seijas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →